Head of Healthcare Corporate Finance and East/Central Life Science, Silicon Valley Bank
Katherine Andersen is a senior market manager covering Healthcare Corporate Finance in the U.S. in addition to the East and Central regions for SVB’s national Life Science practice. She also sits on the Board of Directors for SVB's China Joint Venture. Prior to SVB, Katherine was a Senior Vice President for Wells Fargo Bank leading the Life Sciences business development and relationship management efforts for the New England region. Before that, she was a Director at Wells Fargo Capital Finance focused on front-end business development and underwriting of structured loans, ultimately totaling over $3.0B in commitments. Prior to Wells, she held various positions across mergers and acquisitions, finance, equity derivatives, audit, and management while at Affiliated Managers Group, Merrill Lynch, GE Corporate Audit Staff and GE Capital.
Katherine has a bachelor’s degree in finance and economics from Virginia Tech. She has also completed Dartmouth’s Tuck Executive Leadership and Strategic Impact Program, Wells Fargo’s Transformational Leadership Program, the Program on Negotiation at Harvard Law School and the GE Capital Financial Management Program.
Away from work, Katherine serves on the Finance Advisory Board for Virginia Tech, the Advisory Board for the WEST Organization, and Chairs the Corporate Council for the American Cancer Society’s AstraZeneca Hope Lodge.